Can pathophysiological lung function markers guide the use of postnatal corticosteroids for bronchopulmonary dysplasia?

Can pathophysiological lung function markers guide the use of postnatal corticosteroids for bronchopulmonary dysplasia?

Bibliographic Details
Main Authors:	Kwok, TC, Manley, BJ, Roehr, CC, Sett, A
Format:	Journal article
Language:	English
Published:	Springer Nature 2024

Similar Items

Assessment of postnatal corticosteroids for the prevention of bronchopulmonary dysplasia in preterm neonates: A systematic review and network meta-analysis
by: Ramaswamy, VV, et al.
Published: (2021)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
by: Nilesh Dankhara, et al.
Published: (2023-06-01)

Reviewing the use of corticosteroids in bronchopulmonary dysplasia
by: Fernanda Aparecida de Oliveira Peixoto, et al.
Published: (2016-03-01)

Reviewing the use of corticosteroids in bronchopulmonary dysplasia
by: Fernanda Aparecida de Oliveira Peixoto, et al.
Published: (2016-03-01)

Reviewing the use of corticosteroids in bronchopulmonary dysplasia
by: Fernanda Aparecida de Oliveira Peixoto, et al.
Published: (2016-04-01)

Pulmonary hypertension in bronchopulmonary dysplasia
by: Hansmann, G, et al.
Published: (2020)

Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia.
by: Jonathan L Slaughter, et al.
Published: (2014-01-01)

Surfactant as a drug carrier
by: Sett, A, et al.
Published: (2023)

Postnatal corticosteroid use for prevention or treatment of bronchopulmonary dysplasia in England and Wales 2012–2019: a retrospective population cohort study
by: Neena Modi, et al.
Published: (2022-11-01)

Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Postnatal Risk Factors
by: Li Ding, et al.
Published: (2020-06-01)

Can biomarkers be used to predict bronchopulmonary dysplasia?
by: Vineet Bhandari, et al.
Published: (2021-05-01)

Association between chronic diuretics and postnatal growth in preterm infants with bronchopulmonary dysplasia
by: Anna Wanzenberg, et al.
Published: (2024-06-01)

Editorial: Bronchopulmonary Dysplasia: Past, Current and Future Pathophysiologic Concepts and Their Contribution to Understanding Lung Disease
by: Andrew Bush, et al.
Published: (2022-07-01)

The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment
by: Jennifer J. P. Collins, et al.
Published: (2017-05-01)

Phenotypes of Bronchopulmonary Dysplasia
by: Shih-Hsin Wang, et al.
Published: (2020-08-01)

Bronchopulmonary Dysplasia: An Overview
by: Gisondo CM, et al.
Published: (2020-09-01)

Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions.
by: Brian J Clouse, et al.
Published: (2016-01-01)

Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia.
by: Esther van Mastrigt, et al.
Published: (2018-01-01)

Bronchopulmonary dysplasia: how can we improve its outcomes?
by: Tae-Jung Sung
Published: (2019-10-01)

Present and Future of Bronchopulmonary Dysplasia
by: Luca Bonadies, et al.
Published: (2020-05-01)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
by: Alecia Thompson, et al.
Published: (2008-01-01)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
by: Kun Yang, et al.
Published: (2020-10-01)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
by: Alecia Thompson, et al.
Published: (2008-01-01)

Early prediction of bronchopulmonary dysplasia: can noninvasive monitoring methods be essential?
by: Xuewei Cui, et al.
Published: (2023-04-01)

Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis
by: Zhi-Qun Zhang, et al.
Published: (2017-12-01)

Bronchopulmonary dysplasia: Biomarkers, lung function, and clinical course
by: E. A. Zhdanovich, et al.
Published: (2016-09-01)

Logistic regression analysis in Bronchopulmonary Dysplasia /
by: 238494 Kavitha Samannamuthaliar
Published: (2008)

Prevalence, Prevention and Management of Bronchopulmonary Dysplasia
by: Gilfillan MA, et al.
Published: (2024-01-01)

Development and Disorders of the Airway in Bronchopulmonary Dysplasia
by: Douglas Bush, et al.
Published: (2023-06-01)

Editorial: Bronchopulmonary dysplasia: latest advances
by: Shahana Perveen, et al.
Published: (2023-11-01)

Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia
by: Leif D. Nelin, et al.
Published: (2022-07-01)

Bronchopulmonary Dysplasia: An Update on Experimental Therapeutics
by: Anika Naeem, et al.
Published: (2019-03-01)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
by: Gi Beom Kim
Published: (2010-06-01)

Bronchopulmonary dysplasia: an old and new disease
by: Caterina Franco, et al.
Published: (2014-10-01)

New Pharmacologic Approaches to Bronchopulmonary Dysplasia
by: Roberts K, et al.
Published: (2021-03-01)

An Update on the Prevention and Management of Bronchopulmonary Dysplasia
by: Hennelly M, et al.
Published: (2021-08-01)

Correlation of retinopathy of prematurity with bronchopulmonary dysplasia
by: Podraza Wojciech, et al.
Published: (2018-03-01)

Impact of bronchopulmonary dysplasia on brain and retina
by: Annie Wing Hoi Poon, et al.
Published: (2016-04-01)

Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?
by: Rishika P. Sakaria, et al.
Published: (2022-03-01)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
by: Lidys eRivera, et al.
Published: (2016-03-01)